chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3 weeks after shot, a chickenpox came up on chest and again about 2 weeks later on her leg (if rash flared up badly). On 11/20/00, the night after shot, legs were sore, loss of appetite and continuous cries of pain. By that weekend, still continuous screams of pain and rash broke out and "Mennen's" products starting burning her skin (she had used all their products from birth with no previous problems). When rash breaks out, her right eye seeps as if she has infection in it. Loss of appetite continued until oral steroid was given (Florida), still has problems with it when rash comes back. Since 11/20/00, sleep was affected and would only sleep for a hour at a time and continues to scream of pain (when being picked up or held at times). She had diarrhea from shot until last month (April). The rash will go into blister and skin will seep; glands swell. We've changed her formula for a month (Similac to Soy) with no change. Changed detergents from Tide to Dreft and there is no change. Rinse all clothing and bedding 3 times and no change. Watched for reaction to any food (did not eat "food" until age 5 months, 3 months after shot, not until oral steroids). No allergies. No treatments just lotions, ointments until last of ointment. Steroid creme (way too strong) and antihistamine. No soaps, limited bathing (every 3 days) just water and limited time. Fondak, limited time, Cetaphil soaps and lotion, every other day and no oils. Allergic reaction to treatment with cream and antibiotic (threw papers at me). All may work for a couple of days, then quit.
pt recvd vax; fainting spell;hit head on wall telephone;ice applied to head x 30 mins; no bruises or swelling;BP=90/60, P=68;
pain at injection site; redness and swelling at injection site/1.5 inch swelling circle on her left arm; redness and swelling at injection site; This is a spontaneous report from a contactable consumer (patient's husband) via medical information team. A (Age: 83; Unit: unknown) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration as a single dose on 26Jan2021 for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that he and his wife had their first injection for the Covid-19 vaccine. About 6 hours later patient developed at the injection site, redness and swelling and it was still there today along with some pain in the injection site on 26Jan2021. Patient developed a 1.5 inch swelling circle on her left arm and pain that goes with that. He has a few questions. Reporter wanted to know could that be the vaccine under the red swollen area. Would that swelling be the vaccine where it's staying in place under the skin and will this dissolve over time and does this affect the effectiveness of the vaccine. Since this is the first shot, he assumes this won't interfere with her getting the second shot and asks if that is true. Reporter wanted to know if his wife should get the second dose of the covid vaccine since she had a reaction to the first dose. The outcome of the events were unknown.   Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Information has been received from a physician concerning a 19 week old male with no medical history and no allergies who on 26-MAY-2006 was vaccinated with a first 2mol oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine). There was no concomitant medication. On 27-MAY-2006 the patient experienced vomiting, abdominal pain and crying. It was reported that the patient recovered on 28-MAY-2006. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
symptoms of stroke started approximately 10:00 on 10/14/21 will in the bathroom getting ready.  called for help. found on floor with left facial droop, slurred speech, left side weakness. Called 911. Transported to Hospital. Found to have right MCS stroke. Currently still in hospital under going treatment.
Fever 105.0 F, mayalgia,  arthralgia,  excessive diaphoresis, migraine, chills, nausea, fatigue, loss of appetite, dizziness, excessive thirst, and redness, swelling, pain, itching, blistering at injection site(symptoms have lasted 3 days so far--still exhibiting)
Face flushing/warmth 20 min after shot throughout the entire day. Severe headache, fever and vomiting for 2-3 hours.  Did not have that with 1 or 2nd dose.
Daily stomach pain after the first shot.  After the second shot the stomach pain continued and also had urinary frequency.  Redness at tip of penis
Fever. Chills, sweats, severe headache, malaise, lack of appetite, swollen arm at injection site.
This case was reported by a consumer via call center representative and described the occurrence of shoulder injury in a 37-year-old female patient who received FLUARIX QUADRIVALENT (batch number F3T75, expiry date 31st May 2018) for prophylaxis. On 13th October 2017, the patient received the 1st dose of FLUARIX QUADRIVALENT (intramuscular). On 13th October 2017, less than a day after receiving FLUARIX QUADRIVALENT, the patient experienced shoulder injury, injection site pain, shoulder pain, injected limb mobility decreased and difficulty sleeping. Rechallenge with FLUARIX QUADRIVALENT was positive. On an unknown date, the outcome of the shoulder injury, injection site pain, shoulder pain, injected limb mobility decreased and difficulty sleeping were not recovered/not resolved. It was unknown if the reporter considered the shoulder injury, injection site pain, shoulder pain, injected limb mobility decreased and difficulty sleeping to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The patient was administered FLUARIX QUADRIVALENT in the left deltoid. Last year, after the vaccination, the injection site hurt a lot more than usual (injection site pain) and the pain had been progressing since then to the point that she could no longer move her shoulder (injected limb mobility decreased). The pain kept her up at night and she had lost range of motion. The patient has had a month of pain management and rehabilitation, but she was still experiencing the problem. The patient was told the Flu vaccine she received was manufactured by GlaxoSmithKline, but did not know the name. The batch number of the suspect vaccine was reported as F3Y75, however it was changed to F3T75 as per latest sales data sheet.
Child received Daptacel vaccine to right deltoid on 09/03/2003.  Mom noted swelling and redness to area of injection on 09/04/2003-child complained of slight pain on palpation, other wise complaines of itching.  09/08/2003-child seen in clinic 09/07/2003-area of swelling decreased, redness resolving.
Dizzy  with standing, vertigo. It happens when I stand after sitting and also while I?m laying down at night and different times of the day and night.
no adverse event; Improperly stored administered vaccines; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, historical conditions and concomitant medications were not reported.   On 22-SEP-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # T033166 expiration date 29-SEP-2022 (dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). The suspect vaccine was stored in a temperature from -10 degree Celsius (C) to 8 C for 5 hours and 10 minutes. There was previous temperature excursion - the vaccine was stored in a temperature from -10 C to 8 C for 8 hours and 41 minutes and for 3 hours and 35 minutes. No additional adverse events were reported (no adverse event).   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA006537: US-009507513-2109USA006582: US-009507513-2109USA006583: US-009507513-2109USA006585: US-009507513-2109USA006586: US-009507513-2109USA006587: US-009507513-2109USA006588: US-009507513-2109USA006589: US-009507513-2109USA006590: US-009507513-2109USA006591: US-009507513-2109USA006592: US-009507513-2109USA006593: US-009507513-2109USA006594: US-009507513-2109USA006595: US-009507513-2109USA006596: US-009507513-2109USA006597: US-009507513-2110USA005066:
2hrs post vax pt exp severe h/a, severe joint pain on any movement;fever started 28DEC95 100.7 @ top level, down in AM then up w/activity;seen by MD 2JAN96 could not find any other cause for condition;tx rest;no diarrhea or congestion;
Good Evening, I have attached the VAERS form that I had trouble uploading to the VAERS.  I have also quoted it below because the tablets we have on site will not allow me to type in those areas of the PDF.  The adverse reaction occurred around 12:45 pm on 01/06/2021.  Symptoms ceased within 3 hours after visit.  On follow up, she said her symptoms felt like indigestion and anxiety.  Thank you for your time and understanding. The note is as follows, Vaccine recipient came to the vaccination site at 12:45.  She informed us of her medical history. She had one instance of anaphylactic shock as a baby. She has not had a reaction since. She has an allergy to latex, and two others that are no longer viewable in database. No one on site has access to her file now that she has successfully been vaccinated,  so the following history was obtained  from patient verbally.  I did verify that she is not allergic to polyethylene glycol.  Recipient has taken miralax before with no reaction.  This morning before arrival,  recipient took her normal dose of levothyroxine,  and mesalamine.  She also took one lorazepam before her appointment to treat the anxiety she was feeling leading up to her vaccination. She ate a normal amount for her,  including nuts,  crackers and three 16 oz bottles of water. Before her injection,  medic reviewed all medical history and allergies.  We discussed risks,  and  the expected positive outcome of getting the moderna vaccine.  She verbalized her anxiety,  but attested that she very much wanted the vaccine.  After vaccination,  recipient was speaking clearly, feeling okay,  and she was instructed to wait for 30 minutes of observation.  She told personnel on site that she was having chest pain.  She pointed to her sternum describing a 3/10 pain that felt like pressure.  She said it radiated to her right breast.  She said it felt like indigestion,  and she took 1 dose of her own pepsid in her car while she was waiting her 30 minute period.  Vitals:  SPO2 98%,  pulse 55 bpm steady,  strong. She was offered EMS,  and she declined.  Medical staff recommended calling her pcp ASAP and scheduling a virtual urgent care visit to mitigate her COVID concerns in hospital settings.  Patient then said that she felt ready to go home,  and she was advised to lay with her feet up, sip water,  eat crackers,  and use ice or head to alleviate pain and reduce anxiety.  Recipient felt confident in heading home.  Patient information listed below.
Light rash on chest from lower neck to navel, somewhat itchy No raised skin, lasted 4 days. Attempted to see a dermotologist, refused. (rash resolved itself 2 days later). Periodic itchiness pops-up and disappears in a variety of body locations to date, Benadryl, Noxema resolve it. All of this may have nothing to do w/Shingrix shot I report this only due to chronology of imoculation/Sx but I have experienced itchy skin in past and rash may have been due to exposure to sun (limited but possible - I don't specifically recall sitting in sun long enough to get a sunburn but may have happened).
a 64-years-old patient was accidentally given the Fluzone High Dose/ No AE; a 64-years-old patient was accidentally given the Fluzone High Dose/ No AE; Initial information regarding this unsolicited valid non-serious case received on 29-Sep-2020 from the other health care professional.   The case involved a 64 years old female patient who was accidentally given a 0.7mL dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (lot UJ482AA, expiry date: 30-Jun-2021) via intramuscular route in the right deltoid for prophylactic vaccination on 28-Sep-2020 (Product administered to patient of inappropriate age).  Medical history, past medical treatment, vaccination and family history were not provided.  The patient did not received any concomitant medications.  It was an actual medication error due to inappropriate age at vaccine administration.  It was also a case of overdose.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Information has been received from a 71 year old male consumer reporting on himself, with no pertinent medical history, who in October 2009 (3 years ago), was vaccinated with a dose of ZOSTAVAX (dose, route and lot # not reported). No concomitant medications were reported. It was reported that, on approximately 04-AUG-2012 ("2 months ago"), the patient developed shingles with pain after receiving ZOSTAVAX. The red bumps and blisters appeared on the navel area to the left side of his back. The patient tried hydrocodone and tramadol for pain but developed itchy rash after taking them. The physician switched them (the patient saw a doctor) to TYLENOL and NEURONTIN. VALTREX treatment also reported. No laboratory tests were reported. At the time of the report, the patient's outcome was recovering. Causality was not reported. Additional information has been requested.
On 7/24/01, the pt spiked a temperature of 104F and with the fever also developed a generalized red body rash. She would take liquids but would not eat. The fever did respond to Tylenol. The rash and fever lasted approx. 2 days then disappeared. No other symptoms.
Janssen Covid-19 vaccine EUA First 24 hours, tired and achy.  36 hours in at bedtime felt shivery and cold for a few hours then hot and sweaty for a few more hours. In the morning I felt fine. Very mild symptoms.
near death; serious neurological problems; This is a spontaneous report from a contactable consumers. This consumer reported similar events for three patients. This is the second of three reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter mentioned that people should know there are serious neurological problems associated with the Pfizer vaccine. She knows another 3 people, 2 of them are near death on an unspecified date. The outcome of the event was unknown.  The following information on the batch/lot number has been requested.; Sender's Comments: Linked Report(s) : PFIZER INC-2021596593 same reporter/drug, similar events, different patient;-PFIZER INC-2021596788 same reporter/drug, similar events, different patient
Skin reaction/redness and swelling.  Treated with smz-tmp ds (Bactrim ds) and cephalexin 500mg.  Outcome = resolution of inflammation.
Shortly after vaccine administered patient begin to itch and cough, patient reported to be having bronchospasms but denied the ability to not be able to breath or swallow. Patient was given oral Benadryl 25mg X 2 without relief, epi pen was then used, no relief, albuterol inhaler administered, without relief, and then an updraft was administered at which time patient began to show improvement.  Patient was transferred to ER via ambulance to continue monitoring due to s/sx.  Time of course was roughly a total of 45mins while at our facility, unaware if s/sx continued while at ER.
redness, itchy and tender to the touch at the site of the injection; redness, itchy and tender to the touch at the site of the injection; redness, itchy and tender to the touch at the site of the injection / vaccination was notably more painful at the moment of injection compared to past experience with vaccinations; This spontaneous report was received from a consumer (patient's mother) referring  to a 23 year old female patient.      The patient's concurrent conditions and medical history were not reported. Concomitant therapies included an unspecified influenza vaccine "flu shot several weeks ago without sequelae".   On 21-OCT-2020, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) in the right arm for prophylaxis (dose, dose number, route, lot, and exp date were not reported). The vaccine was administerfed by a medical technician in the office. The reporter mentioned that the patient was notably more painful at the moment of injection compared to past experiences with vaccinations. Then, on 23-OCT-2020, the patient experienced redness, itchy, and tender to the touch at the site of the injection on the upper triceps region of her right arm. The patient denied fever or other symptoms.  The patient did not receive additional vaccines on 21-OCT-2020 and denied having prior episodes like these, following previous vaccinations.   The patient was able to go to work on the reporting day, did not seek medical attention and she did not received treatment.
Patient experienced redness, some bruising, swelling, and itching. Recommended apply cold compresses (ice) and taking oral benadryl and topical hydrocortisone for the itching. Asked about any signs of anaphylaxis, patient denied. She said the reaction was improving but still red and slightly bruised and itching on 10/10/18. Told her if it got any worse and wasn't continuing to get better to contact her PCP.
Sore Arm; Stuffy Nose; Fever; Body Ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), NASAL CONGESTION (Stuffy Nose), HEADACHE (headache), PYREXIA (Fever) and MYALGIA (Body Ache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced HEADACHE (headache). On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm), NASAL CONGESTION (Stuffy Nose), PYREXIA (Fever) and MYALGIA (Body Ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Sore Arm), NASAL CONGESTION (Stuffy Nose), HEADACHE (headache), PYREXIA (Fever) and MYALGIA (Body Ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
got the flu; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 07-Dec-2020.  This case involves a patient of unknown demographics who got the flu (influenza), while the patient received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown.  On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, unspecified time after receiving the vaccine, the patient stated that the first flu shot he/she got he/she got the flu.   It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.      The reporter assessed the causal relationship with suspect vaccine as related.
Right arm (where administered) ached like a bus ran over it for 3 days afterward.  Experienced immediate tingling in right thumb that went away.  Since then, I have a sharp pain in my deltoid, originating in the location of the shot, then radiating through my bicep with any movement of my arm above my side, in any direction.  Cannot sleep at all on the affected side and arm aches like a toothache all night.  Ibuprofen (600-800 mg) slightly mitigates the pain, but it does not last very long.  It has been two weeks and the symptoms are not subsiding at all.
Arm is swollen / swollen from elbow to shoulder; Red, black and blue at injection site; Red, black and blue at injection site; Feeling funny around 10:30am; Arm is itchy; Temperature of 101 degrees F/temperature kept going up; Bad chills; Body aches; Headaches; Red, black and blue at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Arm is swollen / swollen from elbow to shoulder), VACCINATION SITE DISCOLORATION (Red, black and blue at injection site), VACCINATION SITE BRUISING (Red, black and blue at injection site), FEELING ABNORMAL (Feeling funny around 10:30am) and PYREXIA (Temperature of 101 degrees F/temperature kept going up) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee surgery NOS.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PERIPHERAL SWELLING (Arm is swollen / swollen from elbow to shoulder), VACCINATION SITE DISCOLORATION (Red, black and blue at injection site), VACCINATION SITE BRUISING (Red, black and blue at injection site), FEELING ABNORMAL (Feeling funny around 10:30am), PYREXIA (Temperature of 101 degrees F/temperature kept going up), CHILLS (Bad chills), MYALGIA (Body aches), HEADACHE (Headaches), PRURITUS (Arm is itchy) and INJECTION SITE ERYTHEMA (Red, black and blue at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm is swollen / swollen from elbow to shoulder), VACCINATION SITE DISCOLORATION (Red, black and blue at injection site), VACCINATION SITE BRUISING (Red, black and blue at injection site), FEELING ABNORMAL (Feeling funny around 10:30am), PYREXIA (Temperature of 101 degrees F/temperature kept going up), CHILLS (Bad chills), MYALGIA (Body aches) and HEADACHE (Headaches) had resolved and PRURITUS (Arm is itchy) and INJECTION SITE ERYTHEMA (Red, black and blue at injection site) had not resolved. Not Provided          Concomitant product use was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.